tirzepatide chemical name Tirzepatide| CAS 2023788-19-2 - Order from Adipogen Life Sciences File:Tirzepatide structure.svg - Wikimedia Commons
Description
A separate trial tested semaglutide specifically in patients with cirrhosis and found it did not significantly improve fibrosis in that group
It is possible that new agents coming on board may also have a role as bridging therapies in this context, and investigations into this indication could be worthwhile [178]
Bariatric surgery typically produces 25 to 35% body weight loss, exceeding tirzepatide average of 21%
doi:10.1016/j.parkreldis.2014.02.016 172
Diabetic eye disease (retinopathy)
